4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole, 95.0%, 1g

3,5-Dihydroxypyridine, 95.0%, 250mg

1,1-Dimethyl-prop-2-ynylamine, 90.0%, 5g

1,2,3-Benzotriazol, min. 99 %, zur Synthese, 100 g, kunststoffverpackung.

Heptafluorobutyryl Chloride [for Heptafluorobutyration]>95.0%(GC)25g

1-Phenyl-2,5,8,11-tetraoxatridecan-13-ol, 98.0%, 5g

4-BROMO-1-FLUORO-2-ISOCYANATOBENZENE, 95.0%, 1g

Ethyl 4-(1H-imidazol-1-yl)benzoate, 95.0%, 5g

3-(Pyrrolidin-1-yl)propane-1,2-diol, 95+%, 250mg

2-(4-(Benzyloxy)-3-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

1-(3-Chlorophenyl)prop-2-yn-1-one, 95%, 5g

N,N-Bis-Boc-N-allylamine, 97.0%, 1g

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 1g